Oric Pharmaceuticals, Inc. short interest in 2024
In 2024, Oric Pharmaceuticals, Inc.'s disclosed short interest ran from 15.97% of shares outstanding on 12 Jan 2024 to 16.21% on 31 Dec 2024, a change of +0.24 percentage points. The year's high was 18.23% on 15 Aug 2024 and its low 11.89% on 31 Jan 2024, averaging 15.85% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 45.55 days on 13 Dec 2024. Full history: Oric Pharmaceuticals, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 15.97% (12 Jan 2024)
- End of year
- 16.21% (31 Dec 2024)
- Change
- +0.24 pp
- High
- 18.23% (15 Aug 2024)
- Low
- 11.89% (31 Jan 2024)
- Average
- 15.85%
- Highest days to cover
- 45.55 (13 Dec 2024)
- SEC filings marked
- 9
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 15.97% | 38.52 | results (8-K) |
| 31 Jan 2024 | 11.89% | 10.04 | |
| 15 Feb 2024 | 11.99% | 15.77 | |
| 29 Feb 2024 | 11.89% | 9.56 | |
| 15 Mar 2024 | 12.70% | 8.90 | 10-K filed, results (8-K) |
| 28 Mar 2024 | 14.92% | 14.50 | |
| 15 Apr 2024 | 17.28% | 18.14 | |
| 30 Apr 2024 | 15.19% | 22.25 | |
| 15 May 2024 | 15.75% | 27.74 | 10-Q filed, results (8-K) |
| 31 May 2024 | 16.09% | 24.45 | |
| 14 Jun 2024 | 16.62% | 29.38 | |
| 28 Jun 2024 | 17.36% | 13.37 | |
| 15 Jul 2024 | 16.88% | 16.19 | |
| 31 Jul 2024 | 16.89% | 24.05 | |
| 15 Aug 2024 | 18.23% | 23.31 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 17.96% | 36.74 | |
| 13 Sep 2024 | 17.55% | 27.64 | |
| 30 Sep 2024 | 17.38% | 20.64 | |
| 15 Oct 2024 | 17.01% | 36.51 | |
| 31 Oct 2024 | 16.51% | 25.29 | |
| 15 Nov 2024 | 16.24% | 23.54 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 16.00% | 32.59 | |
| 13 Dec 2024 | 15.88% | 45.55 | |
| 31 Dec 2024 | 16.21% | 30.27 |
See also: Oric Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.